CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects antibody (including IgG and IgM) to SARS-CoV-2 S protein on April 20, 2020. Additionally, Vitalant Research Institute is offering the SARS-CoV-2 Reporter Viral Particle Neutralization (RVPN) test.
The situation is rapidly developing and we know you likely have many questions, but you can find all the current information here: Communications
We will be sending updates as we get more details to share with you!
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...